ChemicalBook > CAS DataBase List > 5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride

5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride

Product Name
5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride
CAS No.
1234015-54-3
Chemical Name
5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride
Synonyms
Prexasertib HCl;LY2606368 dihydrochloride;LY2606368 2HCL;LY 2606368;LY-2606368;LY-2606368 (Prexasertib);LY-2606368 dihydrochloride;Prexasertib dihydrochloride;Prexasertib HCl (LY2606368);Prexasertib (LY2606368) 2HCl;Prexasertib 2HCl (LY-2606368)
CBNumber
CB02669661
Molecular Formula
C18H21Cl2N7O2
Formula Weight
438.31104
MOL File
1234015-54-3.mol
More
Less

5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride Property

storage temp. 
Inert atmosphere,Store in freezer, under -20°C
solubility 
DMSO:12.5(Max Conc. mg/mL);28.52(Max Conc. mM)
form 
Solid
color 
Light yellow to yellow
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-3507
Product name
Prexasertib(dihydrochloride)
Purity
99.41%
Packaging
5mg
Price
$110
Updated
2021/12/16
ChemScene
Product number
CS-3507
Product name
Prexasertib(dihydrochloride)
Purity
99.41%
Packaging
10mg
Price
$180
Updated
2021/12/16
ApexBio Technology
Product number
B8313
Product name
5-((5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-yl)amino)pyrazine-2-carbonitrile hydrochloride
Packaging
5mg
Price
$220
Updated
2021/12/16
AK Scientific
Product number
4999DG
Product name
Prexasertibdihydrochloride
Packaging
50mg
Price
$316
Updated
2021/12/16
ApexBio Technology
Product number
B8313
Product name
5-((5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-yl)amino)pyrazine-2-carbonitrile hydrochloride
Packaging
25mg
Price
$660
Updated
2021/12/16
More
Less

5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride Chemical Properties,Usage,Production

Description

Prexasertib HCl is a member of the serine/threonine protein kinase family and is the core protein of cell cycle checkpoints in DNA damage response (DDR).

Uses

Prexasertib dihydrochloride (LY2606368 dihydrochloride) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib dihydrochloride inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib dihydrochloride causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib dihydrochloride shows potent anti-tumor activity[1][2].

Biological Activity

Prexasertib HCl is an ATP-competitive inhibitor of CHK1 with a Ki value of 0.9 nM. In cell-free experiments, the IC50 values of it for CHK2 and RSK were 8 nM and 9 nM, respectively.

in vivo

Prexasertib dihydrochloride (LY2606368 dihydrochloride; 1-10 mg/kg; SC; twice daily for 3 days, rest 4 days; for three cycles) causes growth inhibition in tumor xenografts[1].
? Prexasertib dihydrochloride (15 mg/kg; SC) causes CHK1 inhibition in the blood and the phosphorylation of both H2AX (S139) and RPA2 (S4/S8)[1].

Animal Model:Female CD-1 nu-/nu- mice (26-28 g) with Calu-6 cells[1]
Dosage:1, 3.3, or 10 mg/kg
Administration:SC; twice daily for 3 days, rest 4 days; for three cycles
Result:Caused statistically significant tumor growth inhibition (up to 72.3%).
Animal Model:Female CD-1 nu-/nu- mice (26-28 g) with Calu-6 cells[1]
Dosage:15 mg/kg (Pharmacokinetic Analysis)
Administration:SC (200 μL)
Result:CHK1 was 7 ng/mL at 12 hours and 3 ng/mL by 24 hours in plasma exposures.
Phosphorylation of both H2AX (S139) and RPA2 (S4/S8) was detectable at 4 hours, showing the rapid occurrence of DNA damage.

target

< tr>
TargetValue
Chk1
(Cell-free assay)
0.9 nM(Ki)
Chk2
(Cell-free assay)
8 nM
RSK
(Cell-free assay)
9 nM

IC 50

Chk1: 0.9 nM (Ki); Chk1: <1 nM (IC50); Chk2: 8 nM (IC50)

References

[1] King C, et al. LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms. Mol Cancer Ther. 2015 Sep;14(9):2004-1 DOI:10.1158/1535-7163.MCT-14-1037
[2] Yin Y, et al. Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer. Am J Cancer Res. 2017 Mar 1;7(3):473-483. PMID:28401005

5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride Suppliers

MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Country
United States
ProdList
9923
Advantage
65

1234015-54-3, 5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochlorideRelated Search:


  • 5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride
  • 5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile dihydrochloride
  • LY2606368 dihydrochloride
  • LY-2606368 dihydrochloride
  • Prexasertib (LY2606368) 2HCl
  • Prexasertib HCl (LY2606368)
  • Prexasertib dihydrochloride
  • LY-2606368 (Prexasertib)
  • LY 2606368;LY-2606368
  • LY 2606368;LY-2606368;PREXASERTIB DIHYDROCHLORIDE
  • Prexasertib HCl
  • LY2606368 2HCL
  • Prexasertib 2HCl (LY-2606368)
  • Apoptosis,CDK2,Prexasertib,ARK5,replication,RSK1,inhibit,MELK,DNA,HeLa,LY 2606368,Inhibitor,Prexasertib dihydrochloride,HT-29,double-stranded,BRSK2,ATP-competitive,CDC25A,S296,S516,autophosphorylation,H2AX,LY-2606368,SIK,Checkpoint Kinase (Chk)
  • Prexasertib dihydrochloride, 10 mM in DMSO
  • Prexasertib 2HCl (LY2606368 dihydrochloride)
  • Prexasertib HCl (LY2606368) ,S7178
  • Prexasertib dihydrochloride (LY-2606368 dihydrochloride
  • Prexasertib hydrochloride (LY2606368)
  • 1234015-54-3